Lincoln Pharmaceuticals Limited (LINCOPH)
Market Closed
9 Jan, 09:57
MSE ₹
638. 15
-12.05
-1.8533%
₹
- Market Cap
- P/E Ratio
6% Div Yield
2,082 Volume
- Eps
₹ 650.2
Previous Close Want to track LINCOPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | 14 |
| | | - | 13.81 |
| | | - | 5.03 |
| | | - | 6.7 |
| | | - | 2.4 |
| | | - | 3.88 |
| | | - | 4.1 |
| | | - | 4.01 |
| | | - | 1.35 |
LINCOPH Earnings Reports FAQ
What is the earnings per share (EPS) for LINCOPH?
EPS data for LINCOPH is currently not available, as Lincoln Pharmaceuticals Limited has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 8 years, the earnings growth rate has been approximately 33.97%, reflecting the LINCOPH's performance and MSE market conditions.
When is the next earnings release date?
Lincoln Pharmaceuticals Limited has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lincoln Pharmaceuticals Limited are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LINCOPH at this time, as Lincoln Pharmaceuticals Limited has no recent EPS data to calculate it.
